Related Experiment Video

Updated: Aug 16, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

647

Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of

Kenneth Ssebambulidde1, Seher H Anjum1, Jessica C Hargarten1

  • 1Translational Mycology Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States.

Frontiers in Neurology
|December 19, 2022
PubMed

Insights

Cryptococcal meningoencephalitis (CM) is a common meningitis causing significant mortality and morbidity. This tutorial focuses on managing CM in non-HIV patients, addressing complex cases despite current therapies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Neurology

Background:

  • Cryptococcal meningoencephalitis (CM) is a leading cause of non-viral meningitis in the US, particularly affecting immunocompromised individuals.
  • High mortality (30-50%) and long-term morbidity persist despite treatment, with immune reconstitution and inflammatory syndromes complicating patient management.
  • CM also affects immunocompetent individuals, including those with autoantibodies to granulocyte-macrophage colony-stimulating factor or monogenetic defects.

Purpose of the Study:

  • To provide a practical tutorial on managing cryptococcal meningoencephalitis (CM) in patients without HIV/AIDS.
  • To address the complexities of CM care in diverse patient populations, including those with autoimmune diseases, malignancies, and post-transplant conditioning.
  • To offer guidance for managing CM in previously healthy individuals with specific immune defects.

Main Methods:

  • This tutorial synthesizes current knowledge and clinical best practices for CM management.
  • It focuses on practical approaches to diagnosis and treatment tailored to non-HIV populations.
  • Case examples and management algorithms are implicitly suggested for clarity.

Main Results:

  • Cryptococcal meningoencephalitis presents significant challenges in immunocompromised and immunocompetent hosts.
  • Mortality and morbidity rates remain high, underscoring the need for optimized therapeutic strategies.
  • Management is complicated by immune reconstitution inflammatory syndrome (IRIS) and underlying immune deficiencies.

Conclusions:

  • Effective management of cryptococcal meningoencephalitis requires tailored approaches, especially in non-HIV populations.
  • Understanding specific patient risk factors and immune status is crucial for successful treatment outcomes.
  • This tutorial aims to improve clinical care and reduce the burden of CM in diverse patient groups.
Keywords:
Cryptococcuscryptococcalfungusinfectious diseasesneuroinflammation

More Related Videos

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells09:35

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

Published on: May 19, 2020

9.6K
Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion04:54

Modified Mouse Model of Repetitive Mild Traumatic Brain Injury Incorporating Thinned-Skull Window and Fluid Percussion

Published on: April 19, 2024

622

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
13
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
417
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
11
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
157
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
17
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20